Effect of Fetal Pituitary-Testes Suppression on Brain Sexual Differentiation and Reproductive Function in Male Sheep.

We previously demonstrated that treating fetal lambs on gestational day 62 with the long-acting gonadotrophin-releasing hormone (GnRH) antagonist degarelix (DG) suppresses pituitary-testicular function during midgestation. The objective of this study was to investigate whether impaired gonadotrophic drive during this fetal period has enduring effects on sexual differentiation and reproductive function in adult male sheep. We assessed the effects of prenatal administration of DG, with or without testosterone (T) replacement, on various sexually dimorphic behavioral traits in adult rams, including sexual partner preferences, as well as neuroendocrine responsiveness and testicular function. Our findings revealed that DG treatment had no effect on genital differentiation or somatic growth. There were some indications that DG treatment suppressed juvenile play behavior and adult sexual motivation; however, male-typical sexual differentiation of reproductive behavior, sexual partner preference, and gonadotropin feedback remained unaffected and appeared to be fully masculinized and defeminized. DG-treated rams showed an increased LH response to GnRH stimulation and a decreased T response to human chorionic gonadotropin stimulation, suggesting impaired Leydig cell function and reduced T feedback. Both effects were reversed by cotreatment with T propionate. DG treatment also suppressed the expression of CYP17 messenger RNA, a key enzyme for T biosynthesis. Despite the mild hypogonadism induced by DG treatment, ejaculate volume, sperm motility, and sperm morphology were not affected. In summary, these results suggest that blocking GnRH during midgestation does not have enduring effects on brain sexual differentiation but does negatively affect the testes' capacity to synthesize T.

Mifepristone and PGF2α activate phosphatidylinositol hydrolysis in the ovine corpus luteum.

Two experiments were conducted to determine whether mifepristone (RU486) and PGF2α activate the phosphatidylinositol hydrolysis pathway during the midluteal phase of the ovine estrous cycle. In experiment 1, ewes on day 8 of the cycle were given 10 µg RU486 or vehicle into the ovarian artery with removal of the corpus luteum (CL) after 10 min. Blood collected prior to and after treatment was analyzed for progesterone. Aliquots of CL were incubated with 10 µCi of 3H-inositol and in the presence and absence of PGF2α (10 nM) for 15 min. Exposure of CL to RU486 and PGF2α increased phosphatidylinositol hydrolysis (p < 0.05). Serum progesterone was reduced in both control and RU486-treated ewes (p < 0.05) compared to concentrations before treatments. In experiment 2, aliquots of CL collected from ewes on day 8 of the cycle were incubated with 3H-inositol and exposed to RU486 (2 µM) in the presence and absence of PGF2α (1 µM) for 15 min. Treatments stimulated phosphatidylinositol hydrolysis as in Exp 1 (p < 0.05). Progesterone concentrations in incubation medium were increased in response to RU486 and PGF2α (p < 0.05). Collectively, these data suggest that RU486 and PGF2α act to stimulate phosphatidylinositol hydrolysis in the mature ovine CL.

Resuscitation Compression for Newborn Sheep.

Neonatal maladjustment syndrome is characterized by depressed consciousness, neurologic signs, and reduced or nonexistent suckle reflex. Resuscitation compression (squeezing) has been used in newborn foals and calves to reduce the behavioral symptoms of neonatal maladjustment syndrome. In this review, the authors describe how resuscitation compression can be used in newborn sheep. This technique can improve abnormal neonatal lamb behavior and encourage suckling in resistant lambs.

Developing a modified Apgar scoring system for newborn lambs.

The Apgar (appearance, pulse, grimace, attitude, respiration) score is an accepted method for assessing newborn viability in humans and domestic animals. The purpose of this research was to modify an existing Apgar scoring system for lambs and compare Apgar score with litter size and birth order, as well as time-to-stand and time-to-suckle. Polypay lambs (n = 75) delivered naturally were used for this study. Pulse (<100 bpm = 0; 100-175 bpm = 1; >175 bpm = 2) and respiration (<45% SpO2 = 0; 45-65% SpO2 = 1; >65% SpO2 = 2) were measured with a pulse oximeter attached to the lamb's ear. Appearance, grimace, and attitude were assessed using mucous membrane color (cyanotic = 0; pale = 1; pink = 2); response to nose stimulation (no response = 0; moves head slightly = 1; shakes head = 2); and response to rump stimulation (no movement = 0; moves but no attempt to stand = 1; attempts to stand = 2), respectively. The Apgar score was measured within 5 min of birth (T0), 15 min (T15) and 60 min (T60) after birth. The time-to-stand and time-to-suckle were recorded and compared to Apgar scores. Apgar scores did not differ by litter size or birth order. There were no significant correlations between the Apgar scores and time-to-stand. There was a moderate positive correlation between attitude and time-to-suckle at T0 (R2 = 0.467), which may affect the ingestion of adequate colostrum in a timely manner. Producers may choose to consider using Apgar scoring so that assistance can be provided to lambs before serious complications arise.